NEW YORK (GenomeWeb News) – Cancer diagnostics company Cynvenio Biosystems announced today its sequencing laboratory has received CLIA certification.

As a result, the lab, located in Westlake Village, Calif., can accept clinical samples from most of the US. In April the company received licensure to accept clinical samples from California, one of the states that require other regulatory approval in addition to CLIA certification before a lab offering an LDT can accept patient samples from the state.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.